For instance, the overexpression of human frataxin resulted in the induction of oxidative metabolism in the human colon carcinoma cell lines MIP101, DLD2, and HT29, but not in non-tumor cells, which was associated with a decrease in cell growth and tumor-forming ability, although without increased ROS production [49]. The gene discussed is FXN; the disease is colon carcinoma.